A Randomized Controlled, Trial of the GLP-1 Receptor Agonist Exenatide in Idiopathic Intracranial Hypertension

Identifier	20220215_nanos_sciplatform2_03
Title	A Randomized Controlled, Trial of the GLP-1 Receptor Agonist Exenatide in Idiopathic Intracranial Hypertension
Creator	James Mitchell, Major RAMC
Subject	Pseudotumor Cerebri; High Intracranial Pressure/Headache
Description	Pre-clinical data demonstrates the ability of Exenatide, a GLP-1R agonist, to reduce CSF secretion and ICP.1 Existing GLP- 1R agonists are widely used to treat obesity and diabetes (but do not cause hypoglycaemia).
Date	2022-02
Language	eng
Format	video/mp4
Type	Image/MovingImage
Source	2022 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of	NANOS Annual Meeting 2022: Scientific Platform Session II
Collection	Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher	Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution	North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management	Copyright 2022. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK	ark:/87278/s6b7qn37
Context URL	The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Primary	James Mitchell, Major RAMC
Setname	ehsl_novel_nam
ID	2193599
Reference URL	https://collections.lib.utah.edu/ark:/87278/s6b7qn37